BDBM323588 Retinoic Acid::US10188615, at-RA::US10752616, Code No. atRA::all-trans-retinoic acid::at-RA

SMILES CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CC(O)=O

InChI Key InChIKey=SHGAZHPCJJPHSC-YCNIQYBTSA-N

Data  4 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 323588   

TargetRetinoic acid receptor RXR-alpha(Homo sapiens (Human))
Acucela

US Patent
LigandPNGBDBM323588(Retinoic Acid | US10188615, at-RA | US10752616, Co...)
Affinity DataEC50:  316nMAssay Description:Retinoid nuclear receptor activity is associated with transduction of the non-visual physiologic, pharmacologic, and toxicologic retinoid signals tha...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetRetinoic acid receptor gamma(Homo sapiens (Human))
King''S College London

US Patent
LigandPNGBDBM323588(Retinoic Acid | US10188615, at-RA | US10752616, Co...)
Affinity DataEC50:  0.900nMAssay Description:Transcriptional transactivation assays were performed with gal4 fusion receptor constructs, created using each of the RAR ligand binding domains of e...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetRetinoic acid receptor alpha(Homo sapiens (Human))
King''S College London

US Patent
LigandPNGBDBM323588(Retinoic Acid | US10188615, at-RA | US10752616, Co...)
Affinity DataEC50:  1.20nMAssay Description:Transcriptional transactivation assays were performed with gal4 fusion receptor constructs, created using each of the RAR ligand binding domains of e...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetRetinoic acid receptor beta(Homo sapiens (Human))
King''S College London

US Patent
LigandPNGBDBM323588(Retinoic Acid | US10188615, at-RA | US10752616, Co...)
Affinity DataEC50:  1.88nMAssay Description:Transcriptional transactivation assays were performed with gal4 fusion receptor constructs, created using each of the RAR ligand binding domains of e...More data for this Ligand-Target Pair
In DepthDetails US Patent